Multiple pathways that lead to tissue damage are activated in DM, initializing by hyperglycemia and the increased production of advanced glycation end products (AGEs) and their receptors, leading to polyol and hexosamine pathway activation, and protein kinase C (PKC) isoform production. The gene discussed is PRRT2; the disease is Hyperglycemia.